98%
921
2 minutes
20
The ability to monitor multiple analytes from various classes of compounds in a single analysis can increase throughput and reduce cost when compared to traditional methods of analyses. This method for analyzing free (parent estrogen) and conjugated estrogens (metabolites) along with sulfonamides and tetracyclines utilizes a high pH (10.4) mobile phase with an ammonium hydroxide buffer for both positive- and negative-mode electrospray ionization. A single-step sample preparation by solid-phase extraction (SPE) was used to isolate and concentrate all analytes simultaneously. The analytical method was developed and validated for recoveries at 3 concentration levels for water and soil and produced recoveries of 42-123% and 21-105% respectively. Method detection limits ranged from 0.3 to 1.0 ng/L for water samples and 0.01 to 0.1 ng/g for soils. The method quantification limit ranged from 0.9 to 3.3 ng/L for water samples and 0.06 to 0.7 ng/g for soils. The single-point standard addition calibration procedure was validated across a linear range of MQL to 100 ng/L with ≥82% accuracy against a matrix matched standard curve. Furthermore, sorption of tetracyclines onto glassware was investigated and minimized by 10% using nitric acid-rinsed glassware, while separation parameters were further optimized based on retention time and signal responses. This method has been used for the quantification of estrogens, tetracyclines, and sulfonamides in soil and runoff waters with multiple compounds detected simultaneously in a single analysis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/jf104355x | DOI Listing |
Eur J Pharm Sci
August 2025
Institute of Biomedicine, Faculty of Medicine, University of Turku, FI-20014 University of Turku, Finland; InFLAMES Research Flagship Center, University of Turku, FI-20014 Turku, Finland.
Sulfonation is one of drug metabolism reactions affecting homeostasis of estrogens. C-3 aryl substituted 7-hydroxycoumarins are fluorescent estrogen mimetics; i.e.
View Article and Find Full Text PDFSci Rep
August 2025
Biomedical and Molecular Metabolism Research, Faculty of Natural and Agricultural Sciences, North-West University (Potchefstroom Campus), Potchefstroom, South Africa.
Combined oral contraceptives (COCs) are commonly prescribed for the prevention of pregnancy, as well as numerous other non-contraceptive health reasons. COCs act by suppressing the natural hormonal fluctuations of the menstrual cycle that result in ovulation. No studies have investigated the effects of COC use on endogenous estrogen biotransformation and the production of estrogen metabolites.
View Article and Find Full Text PDFClimacteric
August 2025
Theramex LTD, London, UK.
Objective: Using real-world data, the current study compared the risk of major adverse cardiovascular events (MACE) between two regulated combined oral hormonal products that are currently available to women in the USA: body-identical oral 17β-estradiol/micronized progesterone (E2/P4) and conjugated equine estrogens/medroxyprogesterone acetate (CEE/MPA).
Methods: Women aged ≥40 years treated with E2/P4 or CEE/MPA were selected from a US claims database (April 2019-June 2021). The E2/P4 or CEE/MPA cohorts were defined based on the first dispensation of E2/P4 or CEE/MPA (index) as prescribed in the real world.
Eur J Med Chem
November 2025
School of Chemistry and Chemical Engineering, Chongqing University, Chongqing, 400030, China; Department of Radiation Medicine, College of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China. Electronic address:
Cytochrome CYP1B1 is a member of the monooxygenase subfamily. It can lead to tumorigenesis by catalyzing the activation of a variety of exogenous carcinogens and endogenous estrogens. In addition, overexpression of CYP1B1 in hormone-related tumors can inactivate certain anticancer drugs, leading to resistance.
View Article and Find Full Text PDFMaturitas
September 2025
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy; Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS S. Matteo Foundation, 27100 Pavia, Italy. Electronic address:
Sexual health and well-being are challenged by the biopsychosocial changes associated with menopause. Local estrogen therapy (LET) represents the mainstay of managing genitourinary syndrome of menopause (GSM). However, most studies have investigated the role of LET on signs and symptoms of vulvovaginal atrophy (VVA) without fully capturing the sexual cluster of symptoms that makes women vulnerable to sexual dysfunction.
View Article and Find Full Text PDF